Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim T Brixen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|May 9, 2007
[Persistent polyarticular synovitis after treatment with alendronate]Louise Frederiksen, Peter Junker, Kim T Brixen
Ugeskrift for Laeger|February 20, 2008
[The incidence of tertiary hyperparathyroidism after renal transplantation]Tomas Nielsen, Kim T Brixen, Bente Jespersen
Ugeskrift for Laeger|June 1, 2007
[Effect of aromatase inhibitors on bone metabolism]Lars Folkestad, Jon Kroll Bjerregaard, Nina H Bjarnason, et al.
Basic & Clinical Pharmacology & Toxicology|July 2, 2004
Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosisKim T Brixen, Palle Mark Christensen, Charlotte Ejersted, et al.
Ugeskrift for Laeger|January 16, 2007
[Oesteogenesis imperfecta--genetics, diagnosis and medical treatment]Kim T Brixen, Niels O Illum, Birgitte Hansen, et al.
Ugeskrift for Laeger|April 15, 2008
[Severe anorexia nervosa: five fatal cases]Jimmi Nielsen, Naja E Jeppesen, Kim T Brixen, et al.
Scandinavian Journal of Public Health|May 21, 2010
Persistence to medical treatment of osteoporosis in women at three different clinical settings--a historical cohort studyDorthe S Nielsen, Bente L Langdahl, Ole H Sørensen, et al.
Ugeskrift for Laeger|March 16, 2002
[Pharmaco-economic evaluation of drug therapy osteoporosis. A literature review]Palle Mark Christensen, Kim Brøsen, Kim T Brixen, et al.
Ugeskrift for Laeger|September 15, 2005
[Primary hyperparathyroidism in pregnancy]Morten Munk Frost Nielsen, Jan Stener Jørgensen, Bendt Brock Jacobsen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|May 9, 2007
[Persistent polyarticular synovitis after treatment with alendronate]Louise Frederiksen, Peter Junker, Kim T Brixen
Ugeskrift for Laeger|February 20, 2008
[The incidence of tertiary hyperparathyroidism after renal transplantation]Tomas Nielsen, Kim T Brixen, Bente Jespersen
Ugeskrift for Laeger|June 1, 2007
[Effect of aromatase inhibitors on bone metabolism]Lars Folkestad, Jon Kroll Bjerregaard, Nina H Bjarnason, et al.
Basic & Clinical Pharmacology & Toxicology|July 2, 2004
Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosisKim T Brixen, Palle Mark Christensen, Charlotte Ejersted, et al.
Ugeskrift for Laeger|January 16, 2007
[Oesteogenesis imperfecta--genetics, diagnosis and medical treatment]Kim T Brixen, Niels O Illum, Birgitte Hansen, et al.
Ugeskrift for Laeger|April 15, 2008
[Severe anorexia nervosa: five fatal cases]Jimmi Nielsen, Naja E Jeppesen, Kim T Brixen, et al.
Scandinavian Journal of Public Health|May 21, 2010
Persistence to medical treatment of osteoporosis in women at three different clinical settings--a historical cohort studyDorthe S Nielsen, Bente L Langdahl, Ole H Sørensen, et al.
Ugeskrift for Laeger|March 16, 2002
[Pharmaco-economic evaluation of drug therapy osteoporosis. A literature review]Palle Mark Christensen, Kim Brøsen, Kim T Brixen, et al.
Ugeskrift for Laeger|September 15, 2005
[Primary hyperparathyroidism in pregnancy]Morten Munk Frost Nielsen, Jan Stener Jørgensen, Bendt Brock Jacobsen, et al.
Pageof 1